To have a better understanding of how 2FF enhance anti-PD-L1 effect on ovarian cancer, we conducted single-cell RNA sequencing to characterize the tumor immune microenvironment in mice treated with anti-PD-L1 alone and in combination with 2FF treatment (Supplementary Fig. 3). The gene discussed is CD274; the disease is ovarian carcinoma.